How market shaping works

The goal of our market shaping work is to help ensure vaccine markets work better for lower-income countries. We want the maximum number of people to receive the life-saving and health-protecting benefits of immunisation.

28 September 2020
2 min read
by Gavi Staff
Republish this article

Disclaimer

If you would like to republish this article, please follow these steps: use the HTML below; do not edit the text; include the author’s byline; credit VaccinesWork as the original source; and include the page view counter script.
<article> <h1> <span>How market shaping works</span> </h1> <div><p>The goal of our market shaping work is to help ensure vaccine markets work better for lower-income countries. We want the maximum number of people to receive the life-saving and health-protecting benefits of immunisation.</p> </div> <ul> <li> <b>28 September 2020</b> </li> <li> <b class="me-2">by</b> <span> <a href="https://www.gavi.org/vaccineswork/authors/gavi-staff" hreflang="en">Gavi Staff</a> </span> </li> </ul> <div> <div> <span data-type="column" data-id="84206"></span> <div> <div> <div> <div> <h3>Gavi’s market shaping work aims to:</h3> <ul> <li>ensure adequate and <a href="https://www.gavi.org/our-alliance/strategy/phase-4-2016-2020/market-shaping-goal" title="The market shaping goal (Phase 4)">secure supply of quality vaccines</a></li> <li>evolve prices of vaccines and other immunisation products to appropriate, sustainable levels</li> <li>save money for countries – our approach to market shaping is forecast to deliver savings of US$ 1.3 billion during the <a href="https://www.gavi.org/our-alliance/strategy/phase-4-2016-2020" title="Phase 4 (2016-2020)">2016–2020 strategic period</a></li> <li>incentivise development of suitable, <a href="https://www.gavi.org/our-alliance/strategy/phase-4-2016-2020/vaccine-goal" title="The vaccine goal (Phase 4)">quality vaccines</a> and other immunisation products</li> <li>maximise the number of healthy vaccine markets</li> </ul> <p><img alt="Healthy vaccine markets" data-entity-type data-entity-uuid src="/sites/default/files/vaccineswork/2020/Thumbnail/market-shaping_graphic_vw.jpg" class="align-center" loading="lazy"></p> <p> </p> </div> </div> </div> </div> <span data-type="column" data-id="84216"></span> </div> <div> <div> <div> <div> <div> <h3>Manufacturers</h3> <p>We support manufacturers to ensure timely, predictable availability of suitable, quality products.</p> </div> </div> </div> </div> <span data-type="column" data-id="84251"></span> <div> <div> <div> <div> <h3>Countries</h3> <p>We work with countries to accurately forecast their demand.</p> </div> </div> </div> </div> <span data-type="column" data-id="84231"></span> <div> <div> <div> <div> <h3>Products</h3> <p>We incentivise innovative vaccine products and improved cold chain equipment to meet the evolving needs of countries.</p> </div> </div> </div> </div> <span data-type="column" data-id="84261"></span> <div> <div> <div> <div> <h3>Donors</h3> <p>We help shape markets to sustainably supply Gavi-supported programmes so that donor investments go further, and we maximise our impact.</p> </div> </div> </div> </div> <span data-type="column" data-id="84241"></span> </div> <div> <span data-type="column" data-id="84271"></span> <div> <div> <div> <div> <h3>Supporting healthy vaccine markets is an essential part of Gavi’s strategy</h3> <p>The goal of our <a href="https://www.gavi.org/our-alliance/market-shaping" title="Market Shaping">market shaping work</a> is to help ensure vaccine markets work better for lower-income countries. We want the maximum number of people to receive the life-saving and health-protecting benefits of immunisation.</p> <p>As a growing number of countries transition from Gavi support, our work also ensures that improvements in market conditions are sustainable in the longer term – for countries (regardless of their income level) and for manufacturers.</p> <p><em>Read more about how Gavi has accelerated equitable uptake and coverage of vaccines in <strong><a href="https://www.gavi.org/news/document-library/gavi-progress-report-2019" title="Gavi Progress Report 2019">Gavi’s 2019 Annual Progress Report</a>.</strong></em></p> <p><a href="https://www.gavi.org/news/document-library/gavi-progress-report-2019" title="Gavi Progress Report 2019"><img alt="Download the Gavi progress report 2019" height="647" src="https://www.gavi.org/sites/default/files/programmes-impact/our-impact/apr/apr-download_th_2.jpg" width="1000" loading="lazy"></a></p> </div> </div> </div> </div> <span data-type="column" data-id="84281"></span> </div> </div> <p> <a target="_blank" rel="noopener noreferrer" href="https://www.gavi.org/vaccineswork/how-market-shaping-works">Original article</a> </p><p>This article was originally published on <a target="_blank" rel="noopener noreferrer" href="https://www.gavi.org/vaccineswork">VaccinesWork</a> </p><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-M7H54VD');</script><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-M7H54VD" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript></article>

Tmaximumge/Pxhere

Gavi’s market shaping work aims to:

ensure adequate and secure supply of quality vaccines
evolve prices of vaccines and other immunisation products to appropriate, sustainable levels
save money for countries – our approach to market shaping is forecast to deliver savings of US$ 1.3 billion during the 2016–2020 strategic period
incentivise development of suitable, quality vaccines and other immunisation products
maximise the number of healthy vaccine markets

Manufacturers

We support manufacturers to ensure timely, predictable availability of suitable, quality products.

Countries

We work with countries to accurately forecast their demand.

Products

We incentivise innovative vaccine products and improved cold chain equipment to meet the evolving needs of countries.

Donors

We help shape markets to sustainably supply Gavi-supported programmes so that donor investments go further, and we maximise our impact.

Supporting healthy vaccine markets is an essential part of Gavi’s strategy

As a growing number of countries transition from Gavi support, our work also ensures that improvements in market conditions are sustainable in the longer term – for countries (regardless of their income level) and for manufacturers.

Read more about how Gavi has accelerated equitable uptake and coverage of vaccines in Gavi’s 2019 Annual Progress Report.